A Case of Cobalamin Deficiency and Macrocytic Anemia Secondary to Sunitinib

被引:2
作者
Reed, Jarred P. [1 ]
Chung, Joan [2 ]
Banerjee, Natasha [1 ]
机构
[1] Univ Calif Los Angeles, Med Ctr, Olive View, Oncol, Sylmar, CA 91342 USA
[2] Univ Calif Los Angeles, Med Ctr, Olive View, Internal Med, Sylmar, CA 91342 USA
关键词
sunitinib; macrocytic anemia; cobalamin; folate; toxicity; renal cell carcinoma; tyrosine kinase inhibitor;
D O I
10.7759/cureus.4310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sunitinib is an oral tyrosine kinase inhibitor (TKI) commonly used in the treatment of renal cell carcinoma (RCC). Among a broad range of toxicities, anemia and macrocytosis are common in patients treated with sunitinib. Correlation between sunitinib-associated macrocytosis and cobalamin deficiency has been reported in small case series and retrospective analyses, although others have not found an association. Here, we present a case of transfusion-dependent macrocytic anemia with cobalamin and folate deficiency in a patient with RCC treated with sunitinib.
引用
收藏
页数:4
相关论文
共 8 条
[1]  
Billemont B, 2007, NEW ENGL J MED, V357, P1351
[2]   Macrocytosis and cobalamin deficiency in patients treated with sunitinib [J].
Gillessen, Silke ;
Graf, Lukas ;
Korte, Wolfgang ;
Cerny, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) :2330-2331
[3]   Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatment [J].
Kloth, Jacqueline S. L. ;
Hamberg, Paul ;
Mendelaar, Pauline A. J. ;
Dulfer, Roderick R. ;
van der Holt, Bronno ;
Eechoute, Karel ;
Wiemer, Erik A. C. ;
Kruit, Wim H. J. ;
Sleijfer, Stefan ;
Mathijssen, Ron H. J. .
EUROPEAN JOURNAL OF CANCER, 2016, 56 :101-106
[4]   Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma [J].
Kucharz, Jakub ;
Giza, Agnieszka ;
Dumnicka, Paulina ;
Kuzniewski, Marek ;
Kusnierz-Cabala, Beata ;
Bryniarski, Pawel ;
Herman, Roma ;
Zygulska, Aneta Lidia ;
Krzemieniecki, Krzysztof .
MEDICAL ONCOLOGY, 2016, 33 (10)
[5]   Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Tomczak, Piotr ;
Michaelson, M. Dror ;
Bukowski, Ronald M. ;
Rixe, Olivier ;
Oudard, Stephane ;
Negrier, Sylvie ;
Szczylik, Cezary ;
Kim, Sindy T. ;
Chen, Isan ;
Bycott, Paul W. ;
Baum, Charles M. ;
Figlin, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) :115-124
[6]   Laboratory testing for cobalamin deficiency in megaloblastic anemia [J].
Oberley, Matthew J. ;
Yang, David T. .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (06) :522-526
[7]  
Price J, 2010, CURR ONCOL, V17, P58
[8]   Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma [J].
Rini, Brian I. ;
Choueiri, Toni K. ;
Elson, Paul ;
Khasawneh, Mohamad K. ;
Cotta, Claudiu ;
Unnithan, Jaya ;
Wood, Laura ;
Mekhail, Tarek ;
Garcia, Jorge ;
Dreicer, Robert ;
Bukowski, Ronald M. .
CANCER, 2008, 113 (06) :1309-1314